About this trial
Rationale for conducting the study:
The ROCKET study evaluates the clinical and economic outcomes of robot-assisted total knee arthroplasty (RTKR) compared with conventional total knee arthroplasty (TKR). The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Secondary outcomes include patient-reported knee function, health-related quality of life, self-reported instability, physical activity, radiographic alignment, surgical and technical outcomes, complications, reoperations, revisions, and health-economic outcomes.
Study design:
International multicentre, preference-tolerant, randomized, controlled superiority trial with two treatment arms comparing RTKR with conventional TKR. Participants in the randomized part are allocated 1:1. At selected centres where feasible, an optional participant-blinded randomized component may be implemented. Eligible patients who do not undergo randomization may participate in a parallel observational/preference cohort, which is analysed separately from the primary randomized comparison.
Study population:
Adults aged 18 years and older who are eligible for total knee arthroplasty according to local guidelines and who provide informed consent.
Number of patients:
Up to 1,600 randomized participants. Eligible non-randomized participants may additionally be included in the observational/preference cohort.
Primary outcome:
Proportion of randomized participants achieving FJS ≥80 points at 24 months after surgery.
Long-term follow-up:
Patient-reported and registry-based outcomes are planned at 5 and 10 years after surgery where feasible.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 years and older.
Eligible for total knee arthroplasty according to local guidelines and routines.
Willingness to participate in the study.
Disqualifiers
Patients with extreme malalignment necessitating special implants or techniques.
Patients unfit for surgery due to other medical reasons.
Patients who, for other reasons such as alcohol or substance abuse, are deemed unsuitable to participate in the study.
Patients who, for other reasons, cannot fulfil the required patient-reported outcome measures.
Trial design
Parallel
Treatments tested in this trial
Robot-assisted total knee arthroplasty
Procedure/SurgeryRobot-assisted total knee arthroplasty using an approved robotic surgical system to assist intraoperative planning, bone preparation, implant positioning and balancing according to the participating centre's approved technique.
Conventional total knee arthroplasty
Procedure/SurgeryConventional total knee arthroplasty using standard manual instrumentation according to local clinical routine.
Treatment groups
Trial outcomes
Primary outcomes
Proportion of participants achieving a Forgotten Joint Score (FJS) ≥80 points
The primary endpoint is the proportion of randomized participants achieving an FJS of ≥80 points at 24 months after surgery. The FJS ranges from 0 to 100, with higher scores indicating less awareness of the replaced knee during everyday activities.
Secondary outcomes
Forgotten Joint Score (FJS), continuous score
FJS is scored from 0 to 100, with higher scores indicating less awareness of the replaced knee.
Knee injury and Osteoarthritis Outcome Score (KOOS)
KOOS assesses knee-related pain, symptoms, activities of daily living, sport/recreation and knee-related quality of life. Each subscale ranges from 0 to 100, with higher scores indicating better outcome.
Self-reported knee instability (ADLS items)
Self-reported slipping/partial giving way and buckling/full giving way are assessed using items from the Activities of Daily Living Scale of the Knee Outcome Survey.
EQ-5D and EQ VAS
Health-related quality of life is assessed using EQ-5D and EQ VAS.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Danderyd Hospital
Lead sponsor
Karolinska Institutet
Collaborator